Ovulation induction in patients with resistant polycystic ovarian syndrome: Comparative study of the efficacy of metformin and inofolic
Abstract
Background and purpose: Medicines that reduce insulin levels along with increasing insulin sensitivity have created great hope for the treatment of polycystic ovary syndrome. The aim of this study is to compare the effectiveness of metformin and inofolic in inducing ovulation in patients with resistant polycystic ovary syndrome.
Methodology: This randomized clinical trial study was conducted on 40 patients referred to the infertility clinic with PCOS. Patients were randomly divided into two groups: metformin (receive 1 tablet of 500 mg twice a day) and inofolic (receive 1 sachet twice a day, half an hour before breakfast and half an hour before dinner). The treatment continued for 3 months. During the treatment period, both groups underwent ovulation stimulation (received 5 days of oral administration (clomiphene citrate tablet 100 mg daily or letrozole tablet 5 mg daily)) as well as injectable gonadotropin.
Results: The presence of at least one mature follicle in both groups was completely similar, and the number of mature follicles in both groups had a relatively similar pattern (P = 0.26). The pregnancy rate in the group receiving inofolic and metformin was 25% and 15%, respectively.
Conclusion: The findings of the present study showed that the effectiveness of inositol in terms of improving ovarian function and the occurrence of pregnancy in PCOS patients is similar to metformin.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 40 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.